SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-17-008889
Filing Date
2017-05-05
Accepted
2017-05-04 18:26:22
Documents
49
Period of Report
2017-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q cnat-10q_20170331.htm 10-Q 814462
2 EX-10.1 cnat-ex101_193.htm EX-10.1 19029
3 EX-10.2 cnat-ex102_192.htm EX-10.2 100996
4 EX-10.3 cnat-ex103_191.htm EX-10.3 57549
5 EX-31.1 cnat-ex311_6.htm EX-31.1 10702
6 EX-32.1 cnat-ex321_7.htm EX-32.1 6860
  Complete submission text file 0001564590-17-008889.txt   3721154

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT cnat-20170331.xml EX-101.INS 706820
8 XBRL TAXONOMY EXTENSION SCHEMA cnat-20170331.xsd EX-101.SCH 28900
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cnat-20170331_cal.xml EX-101.CAL 36586
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cnat-20170331_def.xml EX-101.DEF 92975
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE cnat-20170331_lab.xml EX-101.LAB 258910
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cnat-20170331_pre.xml EX-101.PRE 191748
Mailing Address 16745 WEST BERNARDO DRIVE Suite 200 San Diego CA 92127
Business Address 16745 WEST BERNARDO DRIVE Suite 200 San Diego CA 92127 (858) 376-2600
Conatus Pharmaceuticals Inc. (Filer) CIK: 0001383701 (see all company filings)

IRS No.: 203183915 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36003 | Film No.: 17815606
SIC: 2834 Pharmaceutical Preparations